Tonkic Ante, Vukovic Jonatan, Vrebalov Cindro Pavle, Pesutic Pisac Valdi, Tonkic Marija
School of Medicine, University of Split, Soltanska 2, 21000, Split, Croatia.
Department of Gastroenterology and Hepatology, University Hospital of Split, Spinciceva 1, 21000, Split, Croatia.
Wien Klin Wochenschr. 2018 Sep;130(17-18):530-534. doi: 10.1007/s00508-018-1356-6. Epub 2018 Jun 29.
Helicobacter pylori infections represent an important factor in the pathogenesis of chronic gastritis, peptic ulcer, MALT lymphoma and gastric adenocarcinoma. The recently published Maastricht V/Florence consensus report indicated that the urea breath test using 13 C urea still remains the best non-invasive test to diagnose H. pylori infections with high sensitivity and specificity. Among the stool antigen tests, the ELISA monoclonal antibody test is a rational option. Effective therapy should be based only on susceptibility testing in regions with documented high clarithromycin resistance (>15%). Advanced high-resolution endoscopic technologies enable increased diagnostic accuracy for detection of H. pylori infections.
幽门螺杆菌感染是慢性胃炎、消化性溃疡、黏膜相关淋巴组织淋巴瘤和胃腺癌发病机制中的一个重要因素。最近发表的《马斯特里赫特V/佛罗伦萨共识报告》指出,使用13C尿素的尿素呼气试验仍然是诊断幽门螺杆菌感染的最佳非侵入性检测方法,具有高灵敏度和特异性。在粪便抗原检测中,ELISA单克隆抗体检测是一种合理的选择。在记录有高克拉霉素耐药率(>15%)的地区,有效的治疗应仅基于药敏试验。先进的高分辨率内镜技术能够提高幽门螺杆菌感染检测的诊断准确性。